Kathryn Chapman has been made executive director of the association promoting Cambridge's innovation ecosystem.
Kathryn Chapman, photo courtesy of LinkedIn
Kathryn Chapman has been made executive director of Innovate Cambridge, the initiative to promote an innovation ecosystem in Cambridge, UK.
Chapman was director of the Babraham Research Campus, a Cambridge-based innovation centre that nurtures startups in the life sciences. Companies it has helped scale up include ArkVax, which makes vaccine technology, and Concr, which makes cancer treatment tools.
Chapman previously worked for the University of Cambridge’s Milner Therapeutics Institute from 2016 to 2022, becoming deputy director in 2019. The Institute is an innovation hub for the life sciences, gathering startups, academics and large pharmaceutical corporations together to spur ventures.
Innovate Cambridge was set up in 2022 through collaboration between the university, its technology transfer office Cambridge Enterprise, and Cambridge Innovation Capital, the university’s venture capital fund.
Its aim is to establish Cambridge as a centre for investment in startups. Local government, startups, universities, science parks and corporate investors including Arm, AstraZeneca and Microsoft have signed up to its charter.
